Interestingly, patients whose systemic malignancy was in CR at the time of glioma diagnosis were significantly older and exhibited higher Ki-67 indices, yet their survival outcomes did not differ from those with glioma only. This evidence concerns the gene MKI67 and central nervous system cancer.